Q1 Beverages and Alcohol Earnings: Boston Beer (NYSE:SAM) Earns Top Marks As the Q1 earnings season wraps, let's dig into this quarter's best and worst performers in the beverages and alcohol industry, including Boston Beer (NYSE:SAM) and its peers. These companies' performance is influenced by brand strength, marketing strategies, and shifts in consumer preferences. Changing consumption patterns are particularly relevant and can be seen in the explosion of alcoholic craft beer drinks or the steady decline of non-alcoholic sugary sodas. Companies that spend on innovation to meet consumers where they are with regards to trends can reap huge demand benefits while those who ignore trends can see stagnant volumes. Finally, with the advent of the social media, the cost of starting a brand from scratch is much lower, meaning that new entrants can chip away at the market shares of established players. The 13 beverages and alcohol stocks we track reported a decent Q1; on average, revenues were in line with analyst consensus estimates. while next quarter's revenue guidance was 15.8% below consensus. Valuation multiples for many growth stocks have not yet reverted to their early 2021 highs, but the market was optimistic at the end of 2023 due to cooling inflation. The start of 2024 has been a different story as mixed signals have led to market volatility, and beverages and alcohol stocks have had a rough stretch, with share prices down 6.2% on average since the previous earnings results. Best Q1: Boston Beer (NYSE:SAM) Known for its flavorful beverages challenging the status quo, Boston Beer (NYSE:SAM) is a pioneer in craft brewing and a symbol of American innovation in the alcoholic beverage industry. Boston Beer reported revenues of $426.1 million, up 3.9% year on year, topping analysts' expectations by 3.3%. It was a stunning quarter for the company, with an impressive beat of analysts' earnings and operating margin estimates. “I’m thrilled to have recently joined Boston Beer as CEO,” said President and CEO Michael Spillane. Boston Beer Total Revenue The stock is up 4.5% since the results and currently trades at $300. Is now the time to buy Boston Beer? Access our full analysis of the earnings results here, it's free. Molson Coors (NYSE:TAP) Sporting an impressive roster of iconic beer brands, Molson Coors (NYSE:TAP) is a global brewing giant with a rich history dating back more than two centuries. Molson Coors reported revenues of $2.60 billion, up 10.7% year on year, outperforming analysts' expectations by 3.7%. It was a very strong quarter for the company, with a solid beat of analysts' earnings estimates. Molson Coors Total Revenue Molson Coors delivered the biggest analyst estimates beat among its peers. The stock is down 19.6% since the results and currently trades at $51.07. Is now the time to buy Molson Coors? Access our full analysis of the earnings results here, it's free. Weakest Q1: Zevia PBC (NYSE:ZVIA) With a primary focus on soda but also a presence in energy drinks and teas, Zevia (NYSE:ZVIA) is a better-for-you beverage company. Zevia PBC reported revenues of $38.8 million, down 10.4% year on year, falling short of analysts' expectations by 1.6%. It was a weak quarter for the company, with revenue guidance for next quarter missing analysts' expectations. Zevia PBC had the weakest full-year guidance update in the group. The stock is down 33.3% since the results and currently trades at $0.7. Read our full analysis of Zevia PBC's results here. Vita Coco (NASDAQ:COCO) Founded in 2004 followed by a 2021 IPO, The Vita Coco Company (NASDAQ:COCO) offers coconut water products that are a natural way to quench thirst. Vita Coco reported revenues of $111.7 million, up 1.8% year on year, in line with analysts' expectations. It was a very strong quarter for the company, with an impressive beat of analysts' gross margin estimates. Vita Coco achieved the highest full-year guidance raise among its peers. The stock is up 15.9% since the results and currently trades at $28.1. Read our full, actionable report on Vita Coco here, it's free. Celsius (NASDAQ:CELH) With its proprietary MetaPlus formula as the basis for key products, Celsius (NASDAQ:CELH) offers energy drinks that feature natural ingredients to help in fitness and weight management. Celsius reported revenues of $355.7 million, up 36.8% year on year, falling short of analysts' expectations by 8.8%. It was a very strong quarter for the company, with an impressive beat of analysts' earnings estimates. Celsius scored the fastest revenue growth but had the weakest performance against analyst estimates among its peers. The stock is down 28.4% since the results and currently trades at $56.1. Read our full, actionable report on Celsius here, it's free. Join Paid Stock Investor Research Help us make StockStory more helpful to investors like yourself. Join our paid user research session and receive a $50 Amazon gift card for your opinions. Sign up here.
Q1 Beverages and Alcohol Earnings: Boston Beer (NYSE:SAM) Earns Top Marks
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...